Indegene Shares Witness ₹558.85 Crore Block Deals: Key Highlights and Insights

Introduction to Indegene Limited

Indegene Limited is a digital-first, life sciences commercialization company that partners with biopharmaceutical, emerging biotech, and medical device companies. Its focus lies in developing products, accelerating their market entry, and driving impact throughout the product lifecycle. Indegene achieves this through healthcare domain expertise, fit-for-purpose technology, and an agile operating model, enabling businesses to modernize their approaches effectively.

Recent Stock Performance of Indegene

On Tuesday, December 3, Indegene’s share price traded 5.73% lower at ₹628.80 per share on the NSE. Despite this decline, the stock has shown robust growth over the past six months, gaining 25.09%. The company’s performance has been noteworthy since its listing earlier this year.

Significant Block Deals in Indegene

Two substantial block deals were recently reported in Indegene shares:

1. A block deal of ₹184.23 crore for 29,37,501 shares at ₹627.16 per share.
2. Another block deal of ₹374.62 crore for 59,93,928 shares at ₹625 per share.

These transactions underscore significant market activity and investor interest in the stock.

Key Shareholders of Indegene

As per the September quarter data, the major shareholders in Indegene include:

• Nadathur Fareast Pte Ltd: Holds the largest stake at 23.64%.
• CA Dawn Investments: Owns a 20.42% stake.
• Brighton Park Capital: Holds a 12% share in the company.

This diversified ownership indicates strong institutional backing and investor confidence in Indegene’s business model.

Indegene’s IPO and Listing Highlights

Indegene Limited made its debut on the stock exchanges on May 13, 2024, with an impressive premium of 46% over its issue price of ₹452.

• NSE Listing: ₹655 per share, a premium of 44.91%.
• BSE Listing: ₹659.70 per share, a premium of 46%.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.